Adjuvant systemic therapy in melanoma: Relative versus absolute benefit; the number needed to treat (NNT) versus the number needed to harm (NNH)?

Adjuvant (ADJ) systemic therapy has transformed melanoma treatment during the past decade. There are, however, still important unanswered questions that lead to debates on the utility and place of ADJ therapy for melanoma. When ADJ trials are reported, they present a hazard ratio with a significant...

詳細記述

書誌詳細

出版年:	EJC Skin Cancer
主要な著者:	Alexander C.J. van Akkooi, Mario Mandala, Paul Nathan, Andrew Haydon, Michael Postow, Piotr Rutkowski
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2024-12-01
主題:	Melanoma Adjuvant Immunotherapy BRAF Targeted therapy Number needed to treat
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2772611824000053